These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30621692)

  • 1. Participants' awareness of ethical compliance, safety and protection during participation in pharmaceutical industry clinical trials: a controlled survey.
    González-Saldivar G; Rodríguez-Gutiérrez R; Viramontes-Madrid JL; Salcido-Montenegro A; Álvarez-Villalobos NA; González-Nava V; González-González JG
    BMC Med Ethics; 2019 Jan; 20(1):2. PubMed ID: 30621692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical considerations in industry-sponsored multiregional clinical trials.
    Ibia E; Binkowitz B; Saillot JL; Talerico S; Koerner C; Ferreira I; Agarwal A; Metz C; Maman M
    Pharm Stat; 2010; 9(3):230-41. PubMed ID: 20824884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflicts of interest in research involving human beings.
    Greco D; Diniz NM
    J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortcomings of protocols of drug trials in relation to sponsorship as identified by Research Ethics Committees: analysis of comments raised during ethical review.
    van Lent M; Rongen GA; Out HJ
    BMC Med Ethics; 2014 Dec; 15():83. PubMed ID: 25490963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informed consent in clinical research: policies and practices in Singapore.
    Ramachandran AJ
    J Biolaw Bus; 2003; 6(1):65-75. PubMed ID: 15239181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional survey to investigate community understanding of medical research ethics committees.
    Fritschi L; Kelsall HL; Loff B; Slegers C; Zion D; Glass DC
    J Med Ethics; 2015 Jul; 41(7):545-8. PubMed ID: 25605609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The impact of researchers loyal to Big Pharma on the ethics and quality of clinical trials in Latin America].
    Ugalde A; Homedes N
    Salud Colect; 2015 Mar; 11(1):67-86. PubMed ID: 25853831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Independent ethics committees for clinical research in Argentina. An evaluation and a system to guarantee their independence].
    Gonorazky SE
    Medicina (B Aires); 2008; 68(2):113-9. PubMed ID: 18499958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRBs and pharmaceutical company funding of research.
    Jellinek MS; Levine RJ
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract]   [Full Text] [Related]  

  • 11. Disclosing clinical trial results: publicity, significance and independence.
    Liao SM; Sheehan M; Clarke S
    Am J Bioeth; 2009 Aug; 9(8):W3-5. PubMed ID: 19998144
    [No Abstract]   [Full Text] [Related]  

  • 12. Descriptive ethics: a qualitative study of local research ethics committees in Mexico.
    Valdez-Martinez E; Turnbull B; Garduño-Espinosa J; Porter JD
    Dev World Bioeth; 2006 May; 6(2):95-105. PubMed ID: 16594973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical assessment of industry-sponsored clinical trials: a case analysis.
    Miller FG; Shorr AF
    Chest; 2002 Apr; 121(4):1337-42. PubMed ID: 11948071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Exploration of the Protective Effects of Investigators' Ethical Awareness upon Subjects of Drug Clinical Trials in China.
    Zhang L; Huang XX; Chen HF
    J Bioeth Inq; 2018 Mar; 15(1):89-100. PubMed ID: 29230696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 16. Adequate protection for the autonomous research subject? The disclosure of sources of funding and commercialisation in genetic research trials.
    Cote A
    Manit Law J; 2002; 28(3):347-58. PubMed ID: 15162817
    [No Abstract]   [Full Text] [Related]  

  • 17. Harmonization in the regulation of pharmaceutical research and human rights: the need to think globally.
    Dominguez-Urban I
    Cornell Int Law J; 1997; 30(2):245-86. PubMed ID: 12194190
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical research 2: legal and ethical issues in research.
    Endacott R
    Intensive Crit Care Nurs; 2004 Oct; 20(5):313-5. PubMed ID: 15450620
    [No Abstract]   [Full Text] [Related]  

  • 19. An unfortunate experiment? The future of ethical review in New Zealand.
    McMillan J; Bowyer L
    Camb Q Healthc Ethics; 2014 Jul; 23(3):268-71. PubMed ID: 24866915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.